Malfatti Carlos Ricardo Maneck, Dos Santos Fabio Seidel, Wouk Jéssica, da Silva Luiz Augusto, Michel Renan Garcia, Snak André Luiz, Czervinski Tiago, da Cunha Mário A Alves, Barbosa Aneli M, Dekker Robert F H
a Pharmaceutical Science Postgraduate Program , Midwest State University, Campus CEDETEG , Guarapuava , Brazil.
b Teaching of Science and Technology Postgraduate Program , Federal Technological University of Paraná, Campus Ponta Grossa , Ponta Grossa , Brazil.
Pharm Biol. 2017 Dec;55(1):1289-1294. doi: 10.1080/13880209.2017.1299767.
Lasiodiplodan, an exocellular (1→6)-β-d-glucan of molecular weight >1.4 × 10 Da produced by MMPI strain of Lasiodiplodia theobromae (Pat.) Griffon & Maubl. (Brotyosphaeriaceae) is known to exhibit anti-proliferative activity on breast cancer cells (MCF-7), anticoagulant activity when sulfonylated, and reduction in transaminase activity when administered in rats.
The effect of intracerebroventricular (I.C.V) injection of lasiodiplodan on neurotoxicity and behavioural changes induced by d-penicillamine was investigated.
Twenty-four male Wistar rats were initially separated in groups of six and treated with 0.15 μmol/μL of NaCl (Groups Ct and d-Pen) and 0.01 μg/μL of lasiodiplodan (Groups Las and Las + d-Pen). After 15 min, they received 6 μmol/μL of NaCl (Groups Ct and Las) and 2 μmol/μL of d-penicillamine (Groups d-Pen and Las + d-Pen). The animal behavior was observed in an open-field test for 60 min. Twenty-four h later, the animals were sacrificed and histopathological analysis and Thiobarbituric acid reactive substances (TBARS) production measurements were performed.
Lasiodiplodan prevented neurotoxicity induced by d-penicillamine significantly reducing the production of TBARS (308%; p < 0.05), and behavioural signs; convulsive and pre-convulsive. No histopathological alterations in the cerebral cortex were observed.
The reduction of TBARS production and convulsive episodes suggests that the protector effect provided by lasiodiplodan passes thought an antioxidant path, possibly interfering in a cascade of neurochemical events, triggering cell death and convulsive episodes. These results demonstrated that lasiodiplodan can be effective in treating neurotoxicity, and reducing damage triggered by convulsions in neuropathies related to GABAergic system.
Lasiodiplodan是由可可毛色二孢菌(Lasiodiplodia theobromae (Pat.) Griffon & Maubl.)的MMPI菌株产生的一种胞外(1→6)-β-D-葡聚糖,分子量>1.4×10 Da,已知其对乳腺癌细胞(MCF-7)具有抗增殖活性,磺酰化后具有抗凝活性,在大鼠体内给药时可降低转氨酶活性。
研究脑室内(I.C.V)注射Lasiodiplodan对D-青霉胺诱导的神经毒性和行为变化的影响。
24只雄性Wistar大鼠最初分为6组,分别用0.15 μmol/μL的NaCl(Ct组和D-Pen组)和0.01 μg/μL的Lasiodiplodan(Las组和Las + D-Pen组)处理。15分钟后,它们分别接受6 μmol/μL的NaCl(Ct组和Las组)和2 μmol/μL的D-青霉胺(D-Pen组和Las + D-Pen组)。在旷场试验中观察动物行为60分钟。24小时后,处死动物并进行组织病理学分析和硫代巴比妥酸反应性物质(TBARS)生成量测定。
Lasiodiplodan可预防D-青霉胺诱导的神经毒性,显著降低TBARS生成量(308%;p < 0.05)以及惊厥和惊厥前期等行为症状。未观察到大脑皮层的组织病理学改变。
TBARS生成量的减少和惊厥发作表明,Lasiodiplodan提供的保护作用通过抗氧化途径实现,可能干扰了一系列神经化学事件,引发细胞死亡和惊厥发作。这些结果表明,Lasiodiplodan可有效治疗神经毒性,并减少与GABA能系统相关的神经病中惊厥引发的损伤。